<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MASLD patogenezi &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/masld-patogenezi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 24 Nov 2025 05:08:38 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>MASLD patogenezi &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Fructose and Follistatin Worsen Acute MASLD</title>
		<link>https://bioengineer.org/fructose-and-follistatin-worsen-acute-masld/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 24 Nov 2025 05:08:35 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[follistatin sinyal yolu]]></category>
		<category><![CDATA[fruktoz metabolizması]]></category>
		<category><![CDATA[hepatik insülin direnci]]></category>
		<category><![CDATA[lipogenez * **MASLD patogenezi:** Çalışmanın ana odağı olan Metabolik İlişkili Steatoik Karaciğer Hastalığı'nın ilerleme mekanizmaları. * **Fruktoz metabolizması]]></category>
		<category><![CDATA[MASLD patogenezi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/fructose-and-follistatin-worsen-acute-masld/</guid>

					<description><![CDATA[In a groundbreaking study published in Nature Communications slated for 2025, researchers Tao, Stöhr, Tok, and colleagues have unveiled a compelling link between fructose consumption, follistatin modulation, and the exacerbation of Metabolic Associated Steatotic Liver Disease (MASLD) during states of complete hepatic insulin resistance. This research offers critical insights into the mechanistic underpinnings of MASLD [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">300373</post-id>	</item>
	</channel>
</rss>
